{
    "response": "**Overall Treatment Decision:** Yes\u2014treat\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Stroke pathway activation with neurological observations and optimisation of oxygen, glucose and temperature\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Possible acute brainstem stroke Prevents secondary injury\n\n*   **Treatment:** Intermittent pneumatic compression for DVT prophylaxis\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Impaired mobility Safe prior to brain imaging\n\n*   **Treatment:** Swallow screen and aspiration precautions\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Brainstem involvement risks dysphagia Reduces aspiration pneumonia\n\n*   **Treatment:** Physiotherapy and gait aids with falls precautions\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Cerebellar ataxia and unsteady gait Prevents deconditioning and injury\n\n*   **Treatment:** Aspirin 300 mg stat then 75 mg daily\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Start after imaging excludes haemorrhage Hold if thrombolysis/mechanical thrombectomy planned\n\n*   **Treatment:** Intravenous thrombolysis or mechanical thrombectomy (per posterior circulation protocol)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Only if imaging confirms occlusion and patient meets time/eligibility criteria\n\n*   **Treatment:** High-dose intravenous methylprednisolone (1 g daily for 3\u20135 days)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Initiate if MRI suggests demyelinating relapse Exclude active infection first\n\n*   **Treatment:** Secondary stroke prevention (high-intensity statin, antihypertensives, anticoagulation if cardioembolic)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Tailor to aetiology after work-up Avoid premature anticoagulation without diagnosis\n\n*   **Treatment:** Neurosurgical/neuro-oncology referral\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Indicated if cavernoma haemorrhage or intrinsic tumour identified on MRI\n\n\ntreatments = [{\"treatment\": \"Stroke pathway activation with neurological observations and optimisation of oxygen, glucose and temperature\", \"timing\": \"Start Now\", \"reasons\": [\"Possible acute brainstem stroke\", \"Prevents secondary injury\"]}, {\"treatment\": \"Intermittent pneumatic compression for DVT prophylaxis\", \"timing\": \"Start Now\", \"reasons\": [\"Impaired mobility\", \"Safe prior to brain imaging\"]}, {\"treatment\": \"Swallow screen and aspiration precautions\", \"timing\": \"Start Now\", \"reasons\": [\"Brainstem involvement risks dysphagia\", \"Reduces aspiration pneumonia\"]}, {\"treatment\": \"Physiotherapy and gait aids with falls precautions\", \"timing\": \"Start Now\", \"reasons\": [\"Cerebellar ataxia and unsteady gait\", \"Prevents deconditioning and injury\"]}, {\"treatment\": \"Aspirin 300 mg stat then 75 mg daily\", \"timing\": \"Delay\", \"reasons\": [\"Start after imaging excludes haemorrhage\", \"Hold if thrombolysis/mechanical thrombectomy planned\"]}, {\"treatment\": \"Intravenous thrombolysis or mechanical thrombectomy (per posterior circulation protocol)\", \"timing\": \"Delay\", \"reasons\": [\"Only if imaging confirms occlusion and patient meets time/eligibility criteria\"]}, {\"treatment\": \"High-dose intravenous methylprednisolone (1 g daily for 3\\u20135 days)\", \"timing\": \"Delay\", \"reasons\": [\"Initiate if MRI suggests demyelinating relapse\", \"Exclude active infection first\"]}, {\"treatment\": \"Secondary stroke prevention (high-intensity statin, antihypertensives, anticoagulation if cardioembolic)\", \"timing\": \"Delay\", \"reasons\": [\"Tailor to aetiology after work-up\", \"Avoid premature anticoagulation without diagnosis\"]}, {\"treatment\": \"Neurosurgical/neuro-oncology referral\", \"timing\": \"Delay\", \"reasons\": [\"Indicated if cavernoma haemorrhage or intrinsic tumour identified on MRI\"]}]"
}